This review assessed treatments for critically ill infants with bronchiolitis. The authors concluded that, currently, no treatment has been shown to be clearly effective, although surfactant appears promising and corticosteroids or ribavarin may be of benefit. There were some limitations to the review but, overall, the authors' cautious conclusions reflect the evidence.
Methods of synthesis
How were the studies combined? The studies were grouped by intervention. Pooled weighted mean differences (WMDs) with 95% confidence intervals (CIs) were calculated: in duration of mechanical ventilation and duration of ICU stay for surfactant versus control, and in duration of mechanical ventilation and length of hospital stay for systemic corticosteroids versus control. A randomeffects model was used. Studies using other interventions were combined in a narrative.
How were differences between studies investigated?
Statistical heterogeneity was assessed using the chi-squared statistic, taking a P-value of less than 0.05 to indicate significant heterogeneity. Potential reasons for significant heterogeneity were discussed.
Results of the review
Sixteen RCTs (n=523) were included.
Thirteen RCTs reported adequate allocation concealment. Twelve RCTs were double-blinded.
Surfactant (3 RCTs, n=79): the studies showed that, compared with the control, surfactant had no significant effect on days of ventilation (WMD -2.58 days, 95% CI: -5.34, 0.18, P=0.07) but significantly decreased ICU days (WMD -3.3 days, 95% CI: -6.38, -0.23, P=0.04). Statistically significant heterogeneity was found for both meta-analyses (P<0.00001). One RCT found decreases in days ventilated and ICU days that were much more than in the other two RCTs.
Systemic corticosteroids: the studies used different doses and durations of treatment. There was no statistically significant difference between systemic corticosteroids and control for days of ventilation (3 RCTs, n=137; WMD 0.62 days, 95% CI: -2.78, 1.53, P=0.57). Similarly, there was no significant difference for duration of hospital stay (2 RCTs, n=96; WMD -2.44 days, 95% CI: -9.30, 4.42, P=0.5). Significant between-study heterogeneity was found in the second analysis.
Ribavirin (one meta-analysis of 3 RCTs, n=104): the meta-analysis found that, compared with the control, ribavirin significantly reduced days of ventilation (WMD 1.2 days, 95% CI: -3.4, -0.2, P=0.03) and non-statistically significantly reduced hospital stay (WMD -1.9 days, 95% CI: -4.6, 0.9, P=0.20). There was no significant difference between treatments in mortality (relative risk 0.36, 95% CI: 0.07, 1.77, P=0.21). No significant heterogeneity was found for any of these meta-analyses.
Immune globulin (3 RCTs, n=35; 33 and 25 ventilated): the studies used different interventions. None of the studies found any statistically significant difference between immune globulin and the control for days ventilated or hospital stay.
Helium (1 RCT, n=13): the RCT provided no data on the effects of heliox on ICU stay.
There was no statistically significant difference in ICU days or ventilator days between control and vitamin A (1 RCT, n=9 in ICU), erythropoietin (1 RCT, n=44) or interferon (1 RCT, n=6 ventilated).
Authors' conclusions
Currently, no treatment has been shown to be clearly effective for critically ill children with bronchiolitis. The use of a surfactant appeared promising and corticosteroids or ribavarin may be of benefit.
CRD commentary
The review question was clear in terms of the study design, intervention, participants and outcomes. However, the results from three included RCTs were only reported as the results of a published meta-analysis. Several sources were searched, but the searching of only one electronic database might have resulted in the omission of other relevant studies. Including reports in any language minimised the possibility of language bias, while attempts to locate unpublished studies reduced publication bias; the authors stated that there were too few studies to assess publication bias. Two reviewers independently selected studies, assessed validity and extracted the data, thus reducing the potential for bias
